DCx Biotherapeutics Corporation
Biotechnology Research
Harnessing the potential of next-gen antibody drug conjugates to improve patient outcomes
About us
Our vision is to develop a pipeline of 1st- in-class precision drug conjugates that are more efficacious and significantly less toxic than traditional antimitotic or topoisomerase inhibiting ADCs.
- Website
-
www.dcxbio.com
External link for DCx Biotherapeutics Corporation
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Type
- Privately Held
- Founded
- 2024